Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis

OBJECTIVE: To compare the efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC). DESIGN: Systematic review and network meta-analysis. DATA SOURCES: PubMed, Embase, Cochrane Central Register of Contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yi, Liu, Jingting, Cai, Xiuyu, Pan, Zhenkui, Liu, Jun, Yin, Weiqiang, Chen, Hanzhang, Xie, Zhanhong, Liang, Hengrui, Wang, Wei, Guo, Zhihua, Zhao, Shen, Liang, Wenhua, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778694/
https://www.ncbi.nlm.nih.gov/pubmed/31591158
http://dx.doi.org/10.1136/bmj.l5460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778694/
https://www.ncbi.nlm.nih.gov/pubmed/31591158
http://dx.doi.org/10.1136/bmj.l5460

Ejemplares similares